The Impact of CYP3A5 Genotype on the Interaction Between Tacrolimus and Intravenous Nicardipine in Kidney Transplant Recipients

The Impact of CYP3A5 Genotype on the Interaction Between Tacrolimus and Intravenous Nicardipine in Kidney Transplant Recipients

Bibliographic Details
Main Author:	Hooper, David K.
Language:	English
Published:	University of Cincinnati / OhioLINK 2010
Subjects:	Surgery Tacrolimus Kidney Transplant Nicardipine Cytochrome P450 Pharmacogenetics
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=ucin1288982632

Similar Items

Effect of the CYP3A5, CYP3A4, CYP3A7, ABCB1, POR and NR1I2 genes in the pharmacokinetics of tacrolimus in a pediatric cohort with stable serum concentrations after renal transplantation: study protocol.
by: Irene Dapia, et al.
Published: (2017-01-01)

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Teun van Gelder, et al.
Published: (2020-07-01)

CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients
by: Paola Krall, et al.
Published: (2021-04-01)

Tacrolimus Intra-Subject Variability in Adherent Kidney and Liver Transplant Recipients
by: Leino, Abbie D.
Published: (2018)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
by: Son SY, et al.
Published: (2017-01-01)

Commentary: The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Gerold Thölking, et al.
Published: (2021-02-01)

Does a single dose of intravenous nicardipine or nimodipine affect the bispectral index following rapid sequence intubation?
by: Jeong Jin Lee, et al.
Published: (2010-10-01)

Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipients
by: Abdulkareem Albekairy, et al.
Published: (2013-01-01)

Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
by: Chen L, et al.
Published: (2018-03-01)

Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
by: S Dashti-Khavidaki, et al.
Published: (2016-07-01)

SIGNIFICANCE OF CYP3A5 GENE POLYMORPHISM IN SERBIAN RENAL TRANSPLANT PATIENTS
by: Nikola Stefanovi ć, et al.
Published: (2013-03-01)

Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients
by: Yoshiharu Suzuki, et al.
Published: (2021-08-01)

Comparison of Oral Nicardipine and Intravenous Magnesium Sulfate for Preterm Labor Pain Management
by: M. Ghasemi, et al.
Published: (2007-07-01)

Comparison of Oral Nicardipine and Intravenous Magnesium Sulfate for Preterm Labor Pain Management
by: M Movahedi, et al.
Published: (2007-06-01)

CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
by: E. S. Stolyarevich, et al.
Published: (2011-06-01)

Combined use of dexmedetomidine and nicardipine provides better controlled hypotension in elderly patients undergoing orthopedic surgery
by: Xiaorui Zhang, et al.
Published: (2020-11-01)

Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients
by: Sepideh Zununi Vahed, et al.
Published: (2015-02-01)

Comparing the effect of immediate versus delayed initiation of tacrolimus on delayed graft function in Kidney transplant recipients: A randomized open-label clinical trial
by: Maryam Ghadimi, et al.
Published: (2018-01-01)

Effect of tacrolimus on the results of living related kidney donor transplantation
by: V A Goriaĭnov, et al.
Published: (2014-06-01)

A case of tacrolimus-induced encephalopathy after kidney transplantation
by: Myoung Uk Kim, et al.
Published: (2011-01-01)

Relationship between CYP3A5 Polymorphism and Tacrolimus Blood Concentration Changes in Allogeneic Hematopoietic Stem Cell Transplant Recipients during Continuous Infusion
by: Naoki Yoshikawa, et al.
Published: (2021-04-01)

Associação dos polimorfismos do CYP3A5 e da PGP com a farmacocinética do tacrolimus, nefrotoxicidade aguda e rejeição do enxerto após transplante renal
by: Diego Alberto Ciscato Cusinato
Published: (2012)

Associação dos polimorfismos do CYP3A5 e da PGP com a farmacocinética do tacrolimus, nefrotoxicidade aguda e rejeição do enxerto após transplante renal
by: Cusinato, Diego Alberto Ciscato
Published: (2012)

Relationship between 2-Hour Tacrolimus Concentrations and Clinical Outcomes in Long Term Kidney Transplantation
by: Jeffrey Yin, et al.
Published: (2020-04-01)

Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients
by: Charat Thongprayoon, et al.
Published: (2020-07-01)

Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)

Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients
by: Salgado PC, et al.
Published: (2017-03-01)

Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus
by: Pasternak AL, et al.
Published: (2021-03-01)

A case report: acute pancreatitis associated with tacrolimus in kidney transplantation
by: Junnan Xu, et al.
Published: (2019-06-01)

The Impact of CYP3A4*22 on Tacrolimus Pharmacokinetics and Outcome in Clinical Practice at a Single Kidney Transplant Center
by: Emaad Abdel-Kahaar, et al.
Published: (2019-09-01)

Safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection: a systematic review and meta-analysis
by: Morteza Arab Zozani, et al.
Published: (2015-08-01)

Basiliximab induction in living donor kidney transplant with tacrolimus-based triple immunosuppression
by: Shyam Bihari Bansal, et al.
Published: (2019-01-01)

High-performance liquid chromatographic method for the determination of nicardipine in pure, pharmaceutical preparations and plasma and its application to pharmacokinetics in humans
by: Sheikha Mohammed Al-Ghannam, et al.
Published: (2008-12-01)

High-performance liquid chromatographic method for the determination of nicardipine in pure, pharmaceutical preparations and plasma and its application to pharmacokinetics in humans
by: Sheikha M. Al-Ghannam, et al.
Published: (2009-01-01)

Tacrolimus and diabetic ketoacidosis after kidney transplantation in a 15-year-old girl (Case Report)
by: Hadi Sorkhi, et al.
Published: (2016-09-01)

The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
by: Gerold Thölking, et al.
Published: (2021-07-01)

Early serum tacrolimus levels predict long-term chronic kidney disease after liver transplantation
by: Vanessa B. A. Brandão, et al.

Influence of CYP3A5 and ABCB1 polymorphism on tacrolimus drug dosing in South Indian renal allograft recipients
by: M Edwin Fernando, et al.
Published: (2019-01-01)

Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
by: Hideaki Kagaya, et al.
Published: (2018-03-01)